India revives pharma logistics study to map 10-year infrastructure needs

The Department of Pharmaceuticals will appoint up to three entities for a six-month study of logistics gaps across drugs and medical devices, spanning cold chains, customs, warehousing and last-mile delivery. The plan will recommend data-backed investments and tracking upgrades, including AI and blockchain use cases.

— Source publishedThu, 24 Sept, 2026, 18:59 IST·First seen Sun, 27 Sept, 2026, 12:31 IST·Source Financial Express (via Wayback)

What happened

India’s Department of Pharmaceuticals has revived a study to map pharma and medical-device logistics gaps, including cold chains, customs and last-mile

Key facts

  • 10 years
  • 6 months
  • up to three entities
  • 50% decision-making power

Why this matters

Companies with capabilities in pharma cold chains, customs technology, AI-enabled traceability or blockchain tracking should evaluate partnerships and acquisitions that position them for India’s emerging infrastructure priorities.

What to watch

  • Appointment of study entities and publication of scope, regional coverage and stakeholder consultations.
  • Recommendations specifying national standards for track-and-trace, serialization, temperature monitoring, data sharing or blockchain interoperability.
  • Union Budget allocations, production-linked incentives, viability-gap funding or PPP tenders for pharma logistics infrastructure.
  • Changes in CDSCO, NPPA, customs or state drug-control requirements affecting storage, transport, exports or recalls.
  • Major pharma manufacturers, e-pharmacies, hospital chains or distributors issuing RFPs for cold-chain monitoring, warehouse automation or control-tower software.
  • Evidence of pilot corridors linking manufacturing clusters, airports/ports, customs gateways and tier-2/3 last-mile networks.
  • Map exposure to Indian pharma and medical-device cold-chain, warehouse-management, serialization and last-mile delivery vendors.
  • Prioritize partnerships with 3PLs that can provide temperature telemetry, batch traceability, customs documentation and API-based inventory visibility.
  • Assess whether omnichannel pharmacy, hospital and clinic fulfillment networks can use shared micro-fulfillment or regional cold-storage capacity.
  • Build data models for SKU-level expiry, temperature excursions, demand forecasting and recall routing; retain auditable records for potential future standards.
  • Monitor consolidation opportunities among regional cold-chain operators and digital freight/traceability platforms as compliance expectations rise.